Skip to main content
Experience

Fonds de solidarité des travailleurs du Québec (FTQ) co-leads the C$8 million Series A funding round of 7 Generation Capital

Fasken
Reading Time 1 minute read
Share
  • LinkedIn

Overview

Client

Fonds de Solidarite des Travailleurs du Quebec

On July 6, 2022, Fonds de solidarité FTQ announced the closing of a C$8 million Series A funding round of 7 Generation Capital, a Vancouver-based company specializing in the transition of commercial vehicle fleets to electric vehicles and charging infrastructure.

The financing was led jointly by Fonds de solidarité FTQ and Siemens Financial Services, the financial services division of the international company Siemens. This will enable 7 Generation Capital to accelerate the deployment of its electric trucks and buses, as well as the development of its software platform to facilitate project development.

A Fasken team composed of Vincent Laforest-Lapointe, Frédéric St-Jean, Julien Langlois and Geneviève Laliberté advised the Fonds de solidarité FTQ on this transaction.

Jurisdictions

  • British Columbia
  • Québec

Team

  • Vincent Laforest-Lapointe, Partner | Mergers & Acquisitions, Québec, QC, +1 418 640 2028, [email protected]
  • Frédéric St-Jean, Associate | Corporate/Commercial, Québec, QC, +1 418 640 2087, [email protected]
  • Julien Langlois, Partner | Corporate/Commercial, Québec, QC, +1 418 640 2064, [email protected]
  • Geneviève Laliberté, Trademark Agent | Partner | Intellectual Property, Life Sciences, Québec, QC, +1 418 640 2047, [email protected]
Vincent Laforest-Lapointe Avocat/Associate Québec Vincent Laforest-Lapointe Partner | Mergers & Acquisitions Québec, QC +1 418 640 2028
Frédéric St-Jean, Associate | Corporate/Commercial Frédéric St-Jean Associate | Corporate/Commercial Québec, QC +1 418 640 2087
Julien Langlois, Partner | Corporate/Commercial Julien Langlois Partner | Corporate/Commercial Québec, QC +1 418 640 2064
Geneviève Laliberté Étudiante/Summer student Québec Geneviève Laliberté Trademark Agent | Partner | Intellectual Property, Life Sciences Québec, QC +1 418 640 2047